Live Nation Entertainment, Inc. · LYV · FY2026 Q1 · Calendar Q2 2026
LYV Q1 2026: Revenue Beats as Venue Nation Securitization and AI Ticketing Take Center Stage
Live Nation is extending its live-entertainment moat through three compounding levers: owned-venue expansion under Venue Nation (now backed by a 600M euro securitization), AI-driven Ticketmaster improvements, and premium hospitality rollouts. Management maintained its outlook for a robust Q3 and solid Q4, consistent with the prior quarter's double-digit AOI growth stance. The Q1 revenue beat of 6.2% reinforces the demand narrative, while the sizable EPS miss reflects the seasonal loss quarter amplified by Venue Nation ramp costs rather than demand weakness. Regulatory overhang persists but management expects legal expenses to moderate.
Company context
Snapshot as of publicationLive Nation Entertainment, Inc., incorporated in 2005 and formerly known as Live Nation, Inc. until its name change in January 2010, is a global leader in live entertainment, headquartered in Beverly Hills, California. The company's diverse operations are organized into three primary business segments: Concerts, Ticketing, and Sponsorship & Advertising. The Concerts segment is responsible for organizing and promoting live musical performances, utilizing its extensive portfolio of owned or managed venues, as well as various rented third-party locations. This division also oversees the management and operation of music venues, produces major music festivals, develops related content, and offers management and other support services to artists. Through its Ticketing segment, Live Nation manages a comprehensive suite of ticketing operations.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 22, 2026 |
| Susquehanna | Neutral | Positive | Downgrade | Jul 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 21, 2026 |
| UBS | Buy | Buy | Maintain | Jul 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 9, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 10, 2026 |
| Guggenheim | Buy | Buy | Maintain | May 6, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | Feb 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Feb 20, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jan 13, 2026 |
| Roth Capital | Buy | Buy | Maintain | Nov 5, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 23, 2025 |
| Citigroup | Buy | Buy | Maintain | Oct 23, 2025 |
| Benchmark | Buy | Buy | Maintain | Sep 26, 2025 |
| Seaport Global | Buy | Buy | Maintain | Sep 23, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 12, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Jun 10, 2025 |
| Roth MKM | Buy | Buy | Maintain | May 2, 2025 |
| Rosenblatt | Buy | Buy | Maintain | May 2, 2025 |
| Macquarie | Outperform | Outperform | Maintain | Mar 6, 2025 |
| TD Cowen | Buy | Buy | Maintain | Nov 12, 2024 |
| Redburn Atlantic | Buy | Neutral | Upgrade | May 9, 2024 |
| Northcoast Research | Buy | Neutral | Upgrade | Mar 20, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 22, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 2, 2021 |
| Gabelli & Co. | Buy | Buy | Maintain | Apr 14, 2020 |
| G.research | Buy | Buy | Maintain | Apr 14, 2020 |
| CFRA | Buy | Hold | Upgrade | Feb 28, 2020 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jun 11, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| BTIG Research | Buy | Neutral | Upgrade | Jul 24, 2018 |
| BTIG | Buy | Neutral | Upgrade | Jul 24, 2018 |
| William Blair | Outperform | Outperform | Maintain | Jul 21, 2017 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Nov 8, 2016 |
| Albert Fried | Overweight | Overweight | Maintain | Oct 30, 2015 |
| Maxim Group | Buy | Buy | Maintain | May 28, 2015 |
| Stifel Nicolaus | Buy | Hold | Upgrade | May 1, 2015 |
| Stifel | Buy | Hold | Upgrade | May 1, 2015 |
| MKM Partners | Buy | Buy | Maintain | Apr 9, 2015 |
| Albert Fried & Co. | Market Perform | Overweight | Downgrade | Mar 9, 2015 |
| Sterne Agee | Neutral | Buy | Downgrade | May 28, 2014 |
| ISI Group | Buy | Buy | Maintain | Feb 7, 2014 |
| Evercore Partners | Equal Weight | Equal Weight | Maintain | Mar 5, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $184.43. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Jed Kelly | $100 | $181.07 | -45.8% | Jul 28, 2026 |
| Oppenheimer | Jed Kelly | $200 | $179.4 | +8.4% | Jul 28, 2026 |
| BTIG | Analyst unavailable | $215 | $177.92 | +16.6% | Jul 23, 2026 |
| Susquehanna | Analyst unavailable | $186 | $180.86 | +0.9% | Jul 21, 2026 |
| UBS | Batya Levi | $208 | $180.22 | +12.8% | Jul 20, 2026 |
| Roth Capital | Analyst unavailable | $205 | $181.56 | +11.2% | Jul 15, 2026 |
| Wells Fargo | Analyst unavailable | $222 | $182.14 | +20.4% | Jul 9, 2026 |
| Goldman Sachs | Stephen Laszczyk | $202 | $182.14 | +9.5% | Jul 8, 2026 |
| Morgan Stanley | Analyst unavailable | $200 | $168.1 | +8.4% | Jun 10, 2026 |
| Guggenheim | Analyst unavailable | $197 | $157.26 | +6.8% | May 6, 2026 |
| Guggenheim | Curry Baker | $180 | $165.33 | -2.4% | Mar 9, 2026 |
| Goldman Sachs | Analyst unavailable | $175 | $162.67 | -5.1% | Feb 20, 2026 |
| Oppenheimer | Analyst unavailable | $190 | $165.3 | +3.0% | Feb 20, 2026 |
| Evercore ISI | Analyst unavailable | $198 | $166.63 | +7.4% | Feb 20, 2026 |
| Roth Capital | Analyst unavailable | $190 | $166.94 | +3.0% | Feb 20, 2026 |
| UBS | Analyst unavailable | $181 | $157.46 | -1.9% | Feb 20, 2026 |
| Morgan Stanley | Analyst unavailable | $185 | $157.46 | +0.3% | Feb 20, 2026 |
| Roth Capital | Analyst unavailable | $174 | $151.11 | -5.7% | Feb 12, 2026 |
| Jefferies | David Katz | $155 | $148.85 | -16.0% | Jan 13, 2026 |
| Evercore ISI | Vijay Jayant | $188 | $141.75 | +1.9% | Dec 23, 2025 |
| UBS | Analyst unavailable | $164 | $125.61 | -11.1% | Nov 25, 2025 |
| Evercore ISI | Kutgun Maral | $168 | $139.14 | -8.9% | Nov 5, 2025 |
| Roth Capital | Eric Handler | $176 | $138.68 | -4.6% | Nov 5, 2025 |
| Susquehanna | Analyst unavailable | $175 | $148.01 | -5.1% | Nov 3, 2025 |
| Deutsche Bank | Benjamin Soff | $173 | $156.15 | -6.2% | Oct 23, 2025 |
| Seaport Global | David Joyce | $190 | $163.82 | +3.0% | Sep 23, 2025 |
| MoffettNathanson | Robert Fishman | $195 | $161.1 | +5.7% | Aug 18, 2025 |
| Morgan Stanley | Cameron Mansson | $180 | $152.89 | -2.4% | Jul 24, 2025 |
| Susquehanna | Joseph Stauff | $165 | $143.71 | -10.5% | Jun 10, 2025 |
| Rosenblatt Securities | Barton Crockett | $146 | $92.18 | -20.8% | Nov 13, 2024 |
| Roth Capital | Eric Handler | $132 | $115.35 | -28.4% | Oct 16, 2024 |
| Seaport Global | David Joyce | $133 | $115.84 | -27.9% | Oct 15, 2024 |
| Oppenheimer | Jed Kelly | $120 | $94.2 | -34.9% | Sep 6, 2024 |
| Bank of America Securities | Peter Henderson | $125 | $95.34 | -32.2% | Sep 4, 2024 |
| Rosenblatt Securities | Barton Crockett | $123 | $94.77 | -33.3% | Jul 2, 2024 |
| Roth Capital | Eric Handler | $120 | $95.22 | -34.9% | May 24, 2024 |
| Seaport Global | David Joyce | $115 | $93.48 | -37.6% | May 24, 2024 |
| Macquarie | Paul Golding | $125 | $101.4 | -32.2% | May 23, 2024 |
| Guggenheim | Curry Baker | $128 | $92.21 | -30.6% | Apr 17, 2024 |
| Rosenblatt Securities | Barton Crockett | $119 | $101.42 | -35.5% | Apr 11, 2024 |
| Oppenheimer | Jed Kelly | $115 | $100.75 | -37.6% | Jul 28, 2023 |
| Oppenheimer | Jed Kelly | $110 | $98.28 | -40.4% | Jul 21, 2023 |
| Morgan Stanley | Analyst unavailable | $80 | $70.69 | -56.6% | Nov 30, 2022 |
| Citigroup | Analyst unavailable | $82 | $69.82 | -55.5% | Nov 28, 2022 |
| Macquarie | Paul Golding | $105 | $83.66 | -43.1% | Jul 13, 2022 |
| Morgan Stanley | Benjamin Swinburne | $110 | $97.2 | -40.4% | Jun 2, 2022 |
| Wolfe Research | Analyst unavailable | $119 | $95.54 | -35.5% | Jun 2, 2022 |
| Rosenblatt Securities | Analyst unavailable | $139 | $95.35 | -24.6% | May 6, 2022 |
| Rosenblatt Securities | Barton Crockett | $138 | $108.28 | -25.2% | Apr 28, 2022 |
| Rosenblatt Securities | Barton Crockett | $320 | $109.72 | +73.5% | Apr 26, 2022 |
| Guggenheim | Curry Baker | $140 | $116.3 | -24.1% | Mar 25, 2022 |
Track every rating change on LYV the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow LYV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 2026 revenue of $3.79B beat consensus estimates of $3.57B by 6.2%. EPS of -$1.85 significantly missed the estimated -$0.35, reflecting the seasonally weak first quarter compounded by Venue Nation pre-opening costs. The stock rose 6.7% in the reaction window (event-close to next-session close) on 2.3x baseline volume, with a +5.3% abnormal move, indicating the market looked past the EPS loss to focus on revenue strength and forward outlook. Subsequent drift was -4.1%. The bullish score declined from 85 in the prior quarter to 78.
Guidance delta
Guidance sentiment was maintained. Management continued to expect a particularly robust Q3 and solid Q4, consistent with the prior quarter's outlook for double-digit AOI growth in 2026. No explicit upward or downward revision to the full-year outlook was noted in this quarter's call.
Key takeaways
- Revenue beat estimates by 6.2% to $3.79B, while EPS missed at -$1.85 vs -$0.35 estimated, reflecting seasonality and Venue Nation ramp-up costs.
- A 600M euro venue securitization creates a propco structure to fund Venue Nation expansion with flexible capital outside the traditional balance sheet.
- AI-driven improvements to Ticketmaster's on-sale experience and backend operations are being accelerated with new engineering hires.
- Premium hospitality concepts such as the Vinyl Room are being scaled toward up to 30% premium capacity at new venues.
- Legal and regulatory expenses are expected to moderate, though DOJ and FTC matters remain pending and are not yet fully resolved.
Management priorities
- Accelerate Venue Nation venue openings and premium hospitality rollout
- Deploy AI tools across Ticketmaster consumer and B2B experiences
- Replicate sports-team partnership model for venue financing in additional regions
- Grow global touring supply, especially in Latin America and Asia
- Resolve pending regulatory matters and reduce associated legal costs
Related earnings events
Communication ServicesSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T03:50:59.852611+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T03:50:59.849800+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.